Traction, Pressure, and Rapid Muscle Release (TPR) Technique During Intramuscular Injection: Effects on Pain and Patient Satisfaction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBezmialem Vakif University

About this trial

This study will be conducted to evaluate the effect of the Traction, Pressure, and Rapid Muscle Release (TPR) technique, an innovative method used during intramuscular vitamin B12 (cyanocobalamin) injections, on patients' pain and satisfaction levels compared with the conventional injection method.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Voluntary participation in the study

Ability to speak and understand Turkish

Being between 18 and 65 years of age

Having a body mass index (BMI) between 18.5 and 30

Disqualifiers

Presence of a scar, burn, redness, hematoma, bruising, tenderness, or induration at the injection site

History of intramuscular injection in the ventrogluteal region within the last 15 days

Presence of injection-related fear

Diagnosis of Diabetes Mellitus

Trial design

Design model

Parallel

Treatments tested in this trial

  • TPR Injection Technique

    Other intervention

    To examine the effect of the Traction, Pressure, and Rapid Muscle Release (TPR) injection technique, a non-pharmacological method, on patients' pain and satisfaction levels during cyanocobalamin (vitamin B12) intramuscular injection.

Treatment groups

102 Participants
are divided into 2 treatment groups
Group A: TPR Technique GroupExperimental treatment 1 intervention
Group B: Standard Injection Technique GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Patient Information Form

The data collection form, developed by the researchers in line with the current literature, consists of questions regarding the patients' sociodemographic characteristics and anthropometric measurements. The form includes questions about patients' age, gender, marital status, educational level, employment status, history of chronic disease, regular medication use, and previous intramuscular (IM) injection experience, as well as three questions related to anthropometric measurements including height, weight, and body mass index (BMI).

Time frame
Immediately before the administration of the cyanocobalamin (vitamin B12) injection.
2

Visual Analogue Scale (VAS)-Pain

First defined in 1921 and used to assess patients' subjective pain levels, the VAS is a form consisting of a horizontal line 10 cm long. The leftmost part of this measurement tool indicates "no pain," while the rightmost part indicates "unbearable pain." A high score on the scale indicates severe pain, while a low score indicates mild pain. The scale is scored as follows: 0 = no pain, 1-3 = mild pain, 4-6 = moderate pain, and 7-10 = severe pain.

Time frame
Immediately after the administration of the cyanocobalamin (vitamin B12) injection.
3

Visual Comparison Scale for Satisfaction

In this scale, satisfaction levels are determined by scoring between 0 and 10. A score of "0" represents the lowest level of satisfaction, while a score of "10" represents the highest level of satisfaction. Patients are asked to indicate the level of their pain on a scale from 0 to 10, with the numerical value representing the patient's satisfaction level.

Time frame
Immediately after the administration of the cyanocobalamin (vitamin B12) injection.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.